An overview of effective therapies and recent advances in biomarkers for chronic liver diseases and associated liver cancer.

@article{Chatterjee2015AnOO,
  title={An overview of effective therapies and recent advances in biomarkers for chronic liver diseases and associated liver cancer.},
  author={Reshmi Chatterjee and Abhisek Mitra},
  journal={International immunopharmacology},
  year={2015},
  volume={24 2},
  pages={
          335-345
        }
}
Chronic liver diseases (CLDs) such as hepatitis, alcoholic liver disease, nonalcoholic fatty liver, and their downstream effect cancer affect more than a billion of people around the world both symptomatically and asymptomatically. The major limitation for early detection and suitable medical management of CLDs and liver cancer is either the absent of symptoms or their similar manifestations as other diseases. This detection impediment has led to a steady increase in the number of people… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-10 OF 29 CITATIONS

Hepatoprotective Effects of Chinese Medicinal Herbs: A Focus on Anti-Inflammatory and Anti-Oxidative Activities

  • International journal of molecular sciences
  • 2016
VIEW 4 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Oxidative Stress and Inflammation in Hepatic Diseases: Therapeutic Possibilities of N-Acetylcysteine

  • International journal of molecular sciences
  • 2015
VIEW 18 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

References

Publications referenced by this paper.
SHOWING 1-10 OF 149 REFERENCES

NAFLD, NASH and liver cancer

  • Nature Reviews Gastroenterology &Hepatology
  • 2013
VIEW 4 EXCERPTS
HIGHLY INFLUENTIAL

Alcoholic Liver Disease-Related Mortality in the United States: 1980–2003

  • The American Journal of Gastroenterology
  • 2010
VIEW 7 EXCERPTS
HIGHLY INFLUENTIAL

The p53 mutation spectrum in hepatocellular carcinoma from Guangxi, China : role of chronic hepatitis B virus infection and aflatoxin B1 exposure.

  • Liver international : official journal of the International Association for the Study of the Liver
  • 2015
VIEW 1 EXCERPT

Controlled attenuation parameter (CAP) for detection of hepatic steatosis in patients with chronic liver diseases: a prospective study of a native Korean population.

Young Eun Chon, Kyu Sik Jung, +8 authors Kwang-Hyub Han
  • Liver international : official journal of the International Association for the Study of the Liver
  • 2014

Similar Papers

Loading similar papers…